Vitamin C (CAS 50-81-7): Atomic Benchmarks for Cancer & Antiviral Research

Executive Summary: Vitamin C (ascorbic acid) is a water soluble vitamin with well-documented roles as an anticancer agent and apoptosis inducer in cellular and animal models (source). At concentrations between 100–200 μg/mL, it inhibits tumor cell proliferation in murine CT26 colon cancer cells. Doses of 200–1000 μg/mL induce apoptosis in a dose-dependent manner (APExBIO). In vivo, Vitamin C reduces tumor volume in both CT26 and 4T1 tumor-bearing BALB/c mice. Organoid models have established its potential in antiviral research, particularly for hepatitis E virus (HEV) studies (Liu et al., 2025). High-purity Vitamin C (B2064) from APExBIO supports reproducible, high-fidelity experimental workflows in oncology, virology, and oxidative stress modulation.

Biological Rationale

Vitamin C (ascorbic acid) is a six-carbon lactone synthesized naturally in many plants and animals, but not in humans due to the lack of functional gulonolactone oxidase (source). As a water soluble vitamin, it acts as a cofactor for numerous enzymatic reactions, including collagen synthesis and catecholamine biosynthesis. Vitamin C is a potent antioxidant, directly scavenging reactive oxygen species (ROS) and maintaining cellular redox homeostasis. In oncology, its ability to modulate oxidative stress and promote apoptosis underpins its investigation as an anticancer agent. Organoid-based models, such as those used in HEV infection research, have further extended its relevance to antiviral drug discovery (Liu et al., 2025). These properties make Vitamin C a critical tool in both cancer and infectious disease research.

Mechanism of Action of Vitamin C (CAS 50-81-7)

• Antioxidant Activity: Vitamin C donates electrons to neutralize ROS, thereby protecting DNA, proteins, and lipids from oxidative damage (source).
• Anticancer Effects: At >100 μg/mL, Vitamin C inhibits proliferation of CT26 murine colon cancer cells and triggers dose-dependent apoptosis via caspase activation (APExBIO).
• Antiviral Properties: Vitamin C modulates antiviral responses by supporting interferon signaling and maintaining epithelial barrier function in organoid models (Liu et al., 2025).
• Pro-Oxidant Potential (Context-Dependent): In the presence of catalytic metals, high-dose Vitamin C may generate hydrogen peroxide, selectively inducing cytotoxicity in tumor cells (source).

Evidence & Benchmarks

• Vitamin C at 100–200 μg/mL inhibits proliferation of CT26 murine colon cancer cells in vitro (APExBIO, product documentation).
• Concentrations of 200–1000 μg/mL induce apoptosis in CT26 cells in a dose-dependent manner, verified by caspase-3 activation (APExBIO, product documentation).
• In vivo, intraperitoneal administration of Vitamin C reduces tumor volume in CT26 and 4T1 tumor-bearing BALB/c mice (APExBIO, product documentation).
• Vitamin C is highly soluble: ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (with ultrasonic assistance), and ≥5.8 mg/mL in DMSO, enabling diverse experimental applications (APExBIO).
• Organoid-based HEV models highlight Vitamin C's role in antiviral workflows by modulating host response and maintaining epithelial integrity (Liu et al., 2025).
• Purity is confirmed at ≥98% by HPLC and NMR analyses for the B2064 kit (APExBIO).

For a deeper mechanistic analysis, see this review, which details strategic integration of Vitamin C in organoid-based cancer and antiviral studies and expands on the evidence summarized here.

Applications, Limits & Misconceptions

Vitamin C (CAS 50-81-7) is widely used in preclinical cancer research to inhibit tumor cell proliferation and induce apoptosis. It is also applied in antiviral research, such as in organoid-based hepatitis E virus models, where it helps maintain epithelial barrier function and modulate host immunity (Liu et al., 2025). Importantly, its water solubility and high purity make it suitable for cell-based assays and animal studies. While its antioxidant properties are beneficial in many contexts, high-dose pro-oxidant effects are context-dependent and may not generalize across all cancer types.

Contrast: This article updates the benchmarks summarized in Vitamin C (CAS 50-81-7): Anticancer and Antiviral Evidence by aggregating recent organoid-based virology findings, especially regarding HEV, and clarifies workflow integration for translational research.

Common Pitfalls or Misconceptions

• Vitamin C is not universally cytotoxic to all cancer cell lines—sensitivity varies by cell type and context (source).
• High-dose Vitamin C is not a substitute for established chemotherapeutics in clinical settings without supporting data.
• Antiviral effects are model-dependent and have not been universally replicated in clinical trials (Liu et al., 2025).
• Solutions of Vitamin C are unstable at room temperature and should be prepared fresh; long-term storage in solution is discouraged (APExBIO).
• Vitamin C’s pro-oxidant effects require specific conditions (e.g., presence of catalytic metals) and are not inherent to all experimental systems.

Workflow Integration & Parameters

• Formulation: Supplied as a solid; store at -20°C. Use Blue Ice for shipping to maintain integrity (APExBIO).
• Stock Solutions: Prepare immediately before use. For water: dissolve up to 57.9 mg/mL; for ethanol (ultrasonic assistance): up to 12.2 mg/mL; for DMSO: up to 5.8 mg/mL.
• Purity Verification: Each lot undergoes HPLC and NMR analysis (≥98% purity) (APExBIO).
• Experimental Ranges: For in vitro studies, use 100–1000 μg/mL, adjusting for cell line sensitivity.
• Controls: Include vehicle controls and, where applicable, positive apoptosis or antiviral controls.

For advanced experimental strategy, see Vitamin C (CAS 50-81-7): Strategic Frontiers for Translational Research. This article extends the discussion by providing actionable workflows for integrating APExBIO’s Vitamin C in organoid-driven oncology and antiviral experiments.

Conclusion & Outlook

Vitamin C (CAS 50-81-7), as supplied by APExBIO, is a rigorously characterized, high-purity reagent with established benchmarks for inhibiting tumor proliferation and supporting antiviral research. Organoid and animal models validate its multifunctional roles, particularly in cancer and hepatitis E virus studies. Researchers should use validated concentrations, maintain solution stability, and interpret results in the context of cell type and model system. Ongoing advances in organoid technologies and translational workflows will likely refine the applications and mechanistic insights of Vitamin C in preclinical research. For purchasing and further technical details, refer to Vitamin C (CAS 50-81-7) B2064 product page.